Post by
Realtor on Feb 07, 2022 9:33am
next NR
next NR will be on detecting ba2
... then by the end of february or begining of march, an NR on the clinical results + submisssion.
what do you guys (longs) truely think ?
Comment by
terr2 on Feb 07, 2022 9:46am
The next NR will be that the clinical results fall where shy of the FDA's guide lines, and that further adjustments will have to happen before any more testing. This sort of NR would be devastating. AJMO
Comment by
Kaiser on Feb 07, 2022 9:51am
LOL your soft bashing is piss poor. Trolling clown
Comment by
terr2 on Feb 07, 2022 9:58am
I guess what you call soft bashing matches up with the soft decline in the share price this morning. Only on a little bit larger volume which means more people are falling away from Therma Bright.
Comment by
Kaiser on Feb 07, 2022 10:02am
Go back to bag holding AH kid. You're only down 80% so many bag holders from other covid stocks here trolling away. All experts yet their plays are all down BIG hahhahaha
Comment by
terr2 on Feb 07, 2022 10:05am
Remember there is still no submission for approval. Tomorrow never seems to come for Thrm. Go figure!!!!!
Comment by
Kaiser on Feb 07, 2022 10:13am
Yeah we are still waiting. Submission and approval will happen when it happens. If it was a no the fda would have already shot it down. keep trolling tho as if anything you say has any effect here.
Comment by
spygate on Feb 07, 2022 10:35pm
Your guess although fundamentally different than Moose's guess is really the same...neither has any validity and is just that...a guess...one of you may be correct but again its just a guess...people should stop guessing and state facts
Comment by
mooseslayer on Feb 07, 2022 9:48am
I think in the next few days we will see a NR that we have got the last corraborating PCR tests, compiled the results and submitted to the FDA for a[pproval. That should get us north of .50 and the big NR on FDA approval will be a halt, open north of $1 and move higher.
Comment by
nrv090909 on Feb 07, 2022 11:09am
agreed, next NR of tabulation and subbmittal to FDA will bring us to .50's... should hear back probably tomorrow. GLTA - south america and asia need tests badly.